Actor Sung Hoon, a professional mukbang fighter, has been selected as the new face of 'Burger King' in South Korea.
Burger King Korea recently launched a comical new commercial film for the brand's newest menu item, the 'Angry Truffle Whopper' with Sung Hoon as the lead.
In the said commercial film, Sung rode a horse from the countryside to the city as he searched for his beloved "Ang-teu-wha" or 'Angry Truffle Whopper'.
He would probe buses and cars before finding his way to a Burger King restaurant.
Sung Hoon was selected as the ambassador for his soft image and charisma that match the colorful taste of Angry Truffle Whopper.
The Angry Truffle Whopper is an upgrade version of the Truffle Mushroom Whopper for consumers who prefer the truffle flavor and spicy taste.


US Back-to-School Spending Seen Falling as Families Focus on Essentials
Trump, Canada Reach Gordie Howe Bridge Deal Ahead of July 27 Opening
Asian Stocks Rise as AI Chip Rally Offsets Middle East Tensions
Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey
Why financial hardship is more likely if you’re disabled or sick
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement
Booked to travel through the Middle East? Here’s why you shouldn’t cancel your flight
Dollar Slips After Fed Minutes as Iran Tensions, Inflation Risks Keep Markets Cautious
Every generation thinks they had it the toughest, but for Gen Z, they’re probably right
The American mass exodus to Canada amid Trump 2.0 has yet to materialize
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Wall Street Rises as SK Hynix’s Record Nasdaq Debut Steals Spotlight Ahead of U.S. CPI Data
Bernstein Raises 2026 Nickel Price Forecast as Indonesia Tightens Supply
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 



